Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent

Conclusion: Synthetic receptors, particularly WP[6], exhibited high binding affinities towards Sch, and presented a significant potential as supramolecular therapeutics to treat the various side effects of Sch by specifically sequestering Sch in vivo.

Source: Theranostics - June 13, 2019 Category: Molecular Biology Authors: Xiangjun Zhang, Qian Cheng, Lanlan Li, Liqing Shangguan, Chenwen Li, Shengke Li, Feihe Huang, Jianxiang Zhang, Ruibing Wang Tags: Research Paper Source Type: research